Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (206)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
41
2026
3082
2.800
Why?
High-Throughput Nucleotide Sequencing
7
2022
181
1.070
Why?
Genomics
10
2023
271
0.800
Why?
Mutation
14
2022
1338
0.790
Why?
Software
4
2021
280
0.780
Why?
Plasma Cells
7
2025
234
0.710
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
123
0.610
Why?
Tumor Microenvironment
4
2024
274
0.540
Why?
Gene Expression Regulation, Neoplastic
7
2026
868
0.530
Why?
Clonal Evolution
4
2020
59
0.530
Why?
Computational Biology
4
2020
209
0.500
Why?
Algorithms
4
2020
668
0.450
Why?
Neoplasm Recurrence, Local
5
2024
647
0.430
Why?
Humans
50
2026
53246
0.400
Why?
Signal Transduction
6
2026
1748
0.380
Why?
Prognosis
13
2025
2118
0.380
Why?
Translocation, Genetic
7
2022
266
0.370
Why?
Drug Resistance, Neoplasm
2
2026
350
0.370
Why?
Neoplasms
2
2020
1335
0.360
Why?
Gene Expression Profiling
10
2025
1112
0.360
Why?
Positron-Emission Tomography
3
2025
299
0.360
Why?
Hematopoietic Stem Cell Transplantation
3
2024
610
0.350
Why?
Osteolysis
2
2022
74
0.350
Why?
Models, Molecular
1
2013
352
0.350
Why?
Diffusion Magnetic Resonance Imaging
2
2025
133
0.350
Why?
Chromosome Aberrations
3
2023
297
0.330
Why?
Genome, Human
3
2021
121
0.320
Why?
Evolution, Molecular
2
2021
97
0.320
Why?
Osteocytes
2
2024
227
0.320
Why?
Proteins
1
2013
351
0.310
Why?
Bone Marrow
3
2020
359
0.290
Why?
Epigenomics
2
2021
76
0.280
Why?
Disease Progression
8
2025
880
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1043
0.250
Why?
Cell Line, Tumor
6
2026
1470
0.240
Why?
RANK Ligand
2
2024
188
0.240
Why?
rho GTP-Binding Proteins
1
2026
11
0.240
Why?
rho-Associated Kinases
1
2026
21
0.240
Why?
Integrin alpha Chains
1
2026
12
0.240
Why?
Lung Neoplasms
2
2026
645
0.220
Why?
Gene Rearrangement
2
2023
76
0.220
Why?
Oncogenes
3
2021
61
0.220
Why?
Chemokine CCL3
1
2024
12
0.220
Why?
HMGB1 Protein
1
2024
22
0.220
Why?
Antigens, CD
1
2026
217
0.210
Why?
Chemokine CXCL12
1
2024
35
0.210
Why?
Mice
9
2026
5982
0.200
Why?
Bone Resorption
2
2024
304
0.200
Why?
Burkitt Lymphoma
1
2023
27
0.190
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
12
0.190
Why?
Gene Dosage
2
2020
76
0.190
Why?
Neoplasm, Residual
2
2025
171
0.190
Why?
Epigenesis, Genetic
3
2023
412
0.180
Why?
Proto-Oncogene Proteins c-akt
1
2023
171
0.180
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.180
Why?
Neoplasm Proteins
2
2021
330
0.180
Why?
Cell Communication
1
2022
73
0.170
Why?
Telomere Homeostasis
1
2021
11
0.170
Why?
Female
14
2026
28792
0.170
Why?
Polycomb Repressive Complex 2
1
2021
48
0.170
Why?
Transcriptome
3
2025
368
0.170
Why?
Chromosome Deletion
2
2023
138
0.170
Why?
Ubiquitination
1
2021
58
0.170
Why?
Loss of Heterozygosity
2
2018
78
0.170
Why?
Lymphoma, B-Cell
1
2021
60
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.160
Why?
Sequence Analysis, DNA
2
2018
216
0.160
Why?
Cell Cycle
1
2021
237
0.160
Why?
Cell Cycle Proteins
1
2021
170
0.160
Why?
B-Lymphocytes
1
2021
178
0.160
Why?
Lymphoma, Follicular
1
2020
27
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Leukemia, Plasma Cell
1
2020
35
0.150
Why?
Aged
10
2025
10430
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Male
14
2026
27444
0.150
Why?
Animals
9
2026
13528
0.150
Why?
Genes, myc
1
2019
39
0.150
Why?
Aged, 80 and over
6
2025
3495
0.140
Why?
Middle Aged
10
2025
13422
0.140
Why?
Tumor Suppressor Protein p53
2
2017
228
0.140
Why?
Transplantation, Autologous
4
2024
488
0.140
Why?
Mutagenesis
1
2018
59
0.140
Why?
Genome
1
2018
58
0.130
Why?
Homologous Recombination
1
2018
45
0.130
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Flow Cytometry
1
2018
400
0.130
Why?
Survival Rate
4
2021
949
0.130
Why?
DNA Repair
1
2018
197
0.120
Why?
DNA Copy Number Variations
3
2022
117
0.110
Why?
Adult
8
2025
14541
0.110
Why?
Remission Induction
3
2021
222
0.110
Why?
Genes, Neoplasm
1
2015
31
0.110
Why?
Pattern Recognition, Automated
1
2015
38
0.110
Why?
Integrins
2
2026
34
0.110
Why?
Cluster Analysis
1
2015
238
0.110
Why?
Xenograft Model Antitumor Assays
2
2026
228
0.110
Why?
Follow-Up Studies
4
2021
2318
0.100
Why?
Databases, Protein
1
2013
28
0.100
Why?
Protein Structure, Secondary
1
2013
71
0.090
Why?
Sequence Alignment
1
2013
119
0.090
Why?
Neoplasm Invasiveness
2
2026
281
0.090
Why?
Amino Acid Sequence
1
2013
563
0.090
Why?
T-Lymphocytes
2
2024
320
0.090
Why?
Chromatin
2
2023
145
0.080
Why?
Breast Neoplasms
1
2020
1223
0.080
Why?
Adenocarcinoma
1
2015
405
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
In Situ Hybridization, Fluorescence
2
2023
266
0.080
Why?
Tumor Burden
2
2020
132
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Disease Models, Animal
2
2026
1517
0.080
Why?
Clone Cells
2
2021
76
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
69
0.070
Why?
Histones
2
2021
318
0.070
Why?
DNA, Neoplasm
2
2020
146
0.070
Why?
DNA Mutational Analysis
2
2020
179
0.070
Why?
Treatment Outcome
4
2020
5597
0.070
Why?
DNA Methylation
2
2023
592
0.060
Why?
Recurrence
2
2021
694
0.060
Why?
Genomic Instability
2
2018
88
0.060
Why?
Antineoplastic Agents
2
2026
1232
0.060
Why?
rhoA GTP-Binding Protein
1
2026
10
0.060
Why?
Risk Factors
3
2021
4018
0.060
Why?
Cell Proliferation
2
2021
1031
0.060
Why?
Cell Movement
1
2026
279
0.050
Why?
ROC Curve
1
2025
246
0.050
Why?
Internet
2
2018
265
0.050
Why?
Killer Cells, Natural
1
2024
113
0.050
Why?
Ferritins
1
2024
38
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
145
0.050
Why?
Antibodies
1
2024
147
0.050
Why?
Proteasome Inhibitors
1
2024
104
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Oxidative Phosphorylation
1
2023
48
0.050
Why?
Cytogenetic Analysis
1
2023
79
0.050
Why?
B-Cell Maturation Antigen
1
2024
101
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
17
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
95
0.050
Why?
Immunoglobulins
1
2023
76
0.050
Why?
Forkhead Transcription Factors
1
2023
120
0.050
Why?
Retrospective Studies
2
2025
6821
0.050
Why?
Phylogeny
1
2022
231
0.040
Why?
Syndecan-1
1
2021
73
0.040
Why?
Spliceosomes
1
2021
10
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
RNA Splicing
1
2021
43
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Alternative Splicing
1
2021
61
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Aneuploidy
1
2020
17
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
56
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.040
Why?
Phosphoproteins
1
2021
117
0.040
Why?
Ecosystem
1
2021
99
0.040
Why?
Single-Cell Analysis
1
2020
72
0.040
Why?
Mice, Transgenic
1
2021
561
0.040
Why?
DNA
1
2023
535
0.040
Why?
Cell Differentiation
1
2022
681
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
Why?
Melphalan
1
2020
180
0.040
Why?
Genetic Variation
1
2020
223
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
Why?
Osteogenesis
1
2022
374
0.040
Why?
Combined Modality Therapy
1
2021
640
0.040
Why?
Multivariate Analysis
1
2021
598
0.040
Why?
Maintenance Chemotherapy
1
2019
52
0.040
Why?
Apoptosis
1
2024
1139
0.040
Why?
Cell Survival
1
2020
600
0.030
Why?
Promoter Regions, Genetic
1
2020
465
0.030
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.030
Why?
Reproducibility of Results
1
2021
1221
0.030
Why?
Genome-Wide Association Study
1
2018
184
0.030
Why?
Information Dissemination
1
2018
85
0.030
Why?
Fibroblast Growth Factors
1
2017
52
0.030
Why?
STAT3 Transcription Factor
1
2017
89
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1367
0.030
Why?
Prospective Studies
1
2023
2412
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
152
0.030
Why?
Thalidomide
1
2019
378
0.030
Why?
Proportional Hazards Models
1
2018
445
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Kaplan-Meier Estimate
1
2018
487
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Cohort Studies
1
2020
1557
0.030
Why?
Models, Genetic
1
2016
169
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
148
0.030
Why?
Survival Analysis
1
2017
659
0.030
Why?
Stem Cell Transplantation
1
2016
191
0.030
Why?
Dogs
1
2015
186
0.030
Why?
Databases, Genetic
1
2015
82
0.030
Why?
Time Factors
1
2021
2992
0.030
Why?
Sequence Analysis, RNA
1
2015
97
0.030
Why?
Genetic Testing
1
2015
130
0.030
Why?
Longitudinal Studies
1
2016
774
0.030
Why?
Child
1
2023
7384
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description